Yüklüyor......
Exploiting gene expression profiling to identify novel minimal residual disease markers of neuroblastoma
PURPOSE: Minimal residual disease (MRD) presents a significant hurdle to curing metastatic neuroblastoma (NB). Biologic therapies directed against MRD can improve outcome. Evaluating treatment efficacy requires MRD measurement, which serves as surrogate endpoint. Because of tumor heterogeneity, no s...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2008
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2670609/ https://ncbi.nlm.nih.gov/pubmed/18980998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-0541 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|